Page last updated: 2024-08-21

2-tert-butylhydroquinone and Leukemia, Promyelocytic, Acute

2-tert-butylhydroquinone has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diomede, L; Enouf, J; Giannì, M; Launay, S; Machesky, LM; Papp, B1

Other Studies

1 other study(ies) available for 2-tert-butylhydroquinone and Leukemia, Promyelocytic, Acute

ArticleYear
Enhancement of ATRA-induced cell differentiation by inhibition of calcium accumulation into the endoplasmic reticulum: cross-talk between RAR alpha and calcium-dependent signaling.
    Blood, 2003, Apr-15, Volume: 101, Issue:8

    Topics: Calcium; Calcium Signaling; CD11b Antigen; Cell Differentiation; Drug Synergism; Endoplasmic Reticulum; Gene Expression Regulation, Leukemic; HL-60 Cells; Homeostasis; Humans; Hydroquinones; Indoles; Leukemia, Promyelocytic, Acute; NADPH Oxidases; Neoplasm Proteins; Oncogene Proteins, Fusion; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Thapsigargin; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured

2003